Dr. June Choon Wai Yee
Dr June Choon is a lecturer and Health Economics researcher in School of Pharmacy, Monash University Malaysia. June completed her BPharm(Hons) at Universiti Sains Malaysia (USM) in 2006 and thereafter her PhD in 2012. She underwent training as a pharmacist at the country's Centre for Infectious Diseases, Sungai Buloh Hospital from 2006 to 2007. As a registered pharmacist, June was actively involved in various researches in biopharmaceutics and bioequivalence studies for over 20 local pharmaceutical companies during her PhD. She sat on the Joint Ethics Committee of the School of Pharmaceutical Sciences, USM-Hospital Lam Wah Ee on human clinical studies from 2008 - 2012. From 2007 to 2009, June also served as Hon. Secretary and Hon. Treasurer for the Penang Chapter of the Malaysian Pharmaceutical Society.
June received her training in Health Economics at University of York, UK. She joined Monash as a Lecturer in December 2014. She has researched in the field of economic evaluation and health technology assessment over a range of areas, including cardiovascular, psychiatry, oncology, and real-world evidence. Ever since her appointment as the Chair of the Monash Health Economics Forum in 2014, and together with the strong support of the Pharmaceutical Services Division, Ministry of Health, Pharmaceutical Association of Malaysia (PhAMA) and the pharmaceutical industry partners, the Forum has progressed, established itself as one of the most anticipated events on the local healthcare sector calendar. She also served in several advisory panels for pharmaceutical organizations. Together with the team in Monash, she has further established the Health Economics team in Monash School of Pharmacy as the leader in health economics in Malaysia and actively contributing to the future development of health economics research in Malaysia. June has recently been appointed Senior Fellow by The Galen Centre of Health and Social Policy, an independent public policy research and advocacy organisation based in Kuala Lumpur, Malaysia.
- Postgraduate Certificate in Health Economics (PgCert), Department of Economics and Related Studies, University of New York, 2018
- Doctor of Philosophy, University Sains Malaysia, 2010
- Bachelor of Science in Pharmacy (Hons), University Sains Malaysia, 2006
- Health Economics
Book chapter: Interpretation of Laboratory Data and General Physical Examination by Pharmacists by 6 authors: Seeba Zachariah, Kiran Kumar, Shaun Wen Huey Lee, Wai Yee Choon, Saba Naeem and Christine Leong (2018) in "Clinical Pharmacy Education, Practice and Research - Clinical Pharmacy, Drug Information, Pharmacovigilance, Pharmacoeconomics and Clinical Research" by Dixon Thomas in Elsevier, Netherlands, United Kingdom and United States
Scholarly Journals (Refereed Only)
June WY Choon, David BC Wu, HY Chong, William TL Lo, Catherine SY Chong, WS Chung, Eileena MC Chui, Brian Tomlinson, Vivian WY Lee, SC Lee & Kenneth KC Lee, (2018). Real-world evidence of improved healthcare utilization in patients with schizophrenia or schizoaffective disorder after early treatment of paliperidone palmitate once-monthly treatment in Hong Kong, Journal of Medical Economics, 2018 Dec 18:1. https://doi.org/10.1080/13696998.2018.1560749
Hor CP, Fung WY, Ang HA, Lim SC, Kam LY, Sim SW, Lim LH, Choon WY, Wong JW, Ch'ng ASH, Beh KKM, Wee HC, Ong LM, Khan NAK, Sulaiman SAS, Shuaib IL, Bakar 7, Yusof 8, Yusof YM, Abu Bakar F, Tang WS, Teh HL, Wahid NA, Saaidin S, Idris N, Yoon CK, Ong HN, Ganapathy JT, Loo CE3, Samy MM, Zainal H, Dharan SCS, Ooi BY, Teoh PY, Tye YL, Yeoh CA, Low DW, Looi, Yuen KH, (2018). Efficacy of Oral Mixed Tocotrienols in Diabetic Peripheral Neuropathy - a Randomized Clinical Trial, JAMA Neurology. https://doi.org/10.1001/jamaneurol.2017.4609
Ibrahim S, Yee JC, Gupta M, Murugiah MK, Ming LC, (2016). Safety and efficacy of health supplement for weight Loss, Arch Pharma Pract 2016;7:S11-5. DOI: 10.4103/2045-080X.183031
Ab Rahman WA, Lee KS, Yee JC, Gupta M, Ming LC (2016). Evidence of Garcinia cambogia as a fat burning and appetite suppressing agents, Arch Pharma Pract 2016;7:S22-8.
Nuri TH, Yee JC, Gupta M, Khan MA, Ming LC, (2016). A review of Panax ginseng as an herbal medicine, Arch Pharma Pract 2016;7:S61-5.
Ali SA, Manan MM, Hassali MA, Kassab YW, Choon WY and Masri MB, (2013). Use of Generic Medicines: Perspectives of consumers living in urban and suburban areas of Klang Valley in Malaysia, Journal of Medical Marketing, Vol 13, Issue 4, Nov 2013 pp. 242 – 250
Zaheer-Ud-Din Babar, PhD, Nur Rashidah Mohd Zaini, MRCPCH, Choon Wai Yee, BPharm, (2006). Harm Reduction Program and Methadone Poisoning: Implications for Pediatric Public Health in Malaysia, Journal of Pharmacy Practice 19;5:1-2, 2006
Conference Proceeding (refereed Only)
Challenges facing the healthcare system in Malaysia. June WY Choon, Kenneth KC Lee. News Across Asia Volume 8 No. 2 (July 2019). ISPOR News Across: Asia Pacific
Healthcare Financing and Efficiency Drivers in 3 Asean Countries – Singapore, Malaysia and Indonesia. Choon WY, Yang S, Lee KKC. Value in Health, ISPOR 2019, New Orleans, US
Cost comparison of gliclazide modified-release and generic gliclazide in preventing end stage renal disease in type 2 diabetes mellitus in the public sector of Malaysia. Choon WY, Subramaniam T, Lee KKC. Value in health. ISPOR European Congress 2019.
Real world evidence of improved healthcare utilization in patients with recent onset schizophrenia afterpaliperidone Palmitate once=monthly treatment in Hong Kong. International Society For Pharmacoeconomics and Outcomes Research (ISPOR) Asia Pacific, Tokyo, Japan, 2018.
Cost-effectiveness of Edoxaban in patients with non-valvular atrial fibrillation in Hong Kong. International Society For Pharmacoeconomics and Outcomes Research (ISPOR) Asia Pacific, Tokyo, Japan, 2018.
Choon JWY, Wu DBC, Lee KKC, (2017). A Preliminary Cost Analysis of Schizophrenic Patients Who Are Stabilized on 1-Monthly Long Acting Paliperidone Palmitate Injection Are Switched to the 3-Monthly Formulation in the Public Health Sector of Hong Kong. International Society For Pharmacoeconomics and Outcomes Research (ISPOR) 20th Annual European Congress, Glasglow 2017.
Wu DBC, Choon JWY, Lee KKC, (2017). Cost-Effectiveness of Edoxaban in Patients with Non-Valvular Atrial Fibrillation in Hong Kong. International Society For Pharmacoeconomics and Outcomes Research (ISPOR) 20th Annual
European Congress, Glasglow 2017.
Choon JWY, Wu DBC, Tomlinson B, Hu M, Chung WS, Lee SC, Lee VWY, Lee KKC, (2016). Outcomes Prediction Using a Generalized Linear Model in a Cohort of Schizophrenic Patients Receiving Paliperidone Long Acting Injectable Treatment in Hong Kong. International Society For Pharmacoeconomics and Outcomes Research (ISPOR) 19th Annual European Congress, Vienna, Austria 2016.
Choon JWY, Wu DBC, Tomlinson B, Hu M, Chung WS, Lee SC, Lee VWY, Lee KKC, (2016). A Preliminary Analysis of Health Care Resource Utilization of Paliperidone Palmitate in the Treatment of Schizophrenia in the Public Health Care Sector of Hong Kong. International Society For Pharmacoeconomics and Outcomes Research (ISPOR) 21st Annual International Meeting, Washington, DC USA. 2016
Antibiotic Prescription Practice For Severe Community-Acquired Pneumonia in the ICU, 10th Malaysian Thoracic
Other (Non-Refereed Publications Included)
Real-World Evidence: Shifting the Dialogue in Medicine Regulation. June Choon. Opinion, CodeBlue (The Galen Centre for Health and Social Policy). February 7, 2020.
The Importance of Well-Designed Studies in Health Care Research. June Choon. Letter, CodeBlue (The Galen Centre for Health and Social Policy). February 6, 2020.
Digital Disruption In Health Care: Keep Pace, Evolve, Or Get Left Behind. June Choon. Opinion, CodeBlue (The Galen Centre for Health and Social Policy). January 30, 2020.
Revisiting the Costs of Medicine Price Controls. June Choon. Opinion, CodeBlue (The Galen Centre for Health and Social Policy). December 13, 2019.
Insight on Generic medicines and Bioequivalence, Pharmacy Practice, Pharmacy Today (MIMS Pharmacy), Oct 2015 issue
Research Grants (Co-Investigator)
Prof Kenneth Lee, Dr David Wu, Dr June Choon, (2016-2018). Cost effectiveness of Edoxaban in Patients with non-valvular atrial fibrillation and venous thromboembolism in Hong Kong, Daiichi Sankyo Hong Kong Ltd, HKD240,000.00
Prof Kenneth Lee, Dr David Wu, Dr June Choon, (2014-current). Health care utilization analysis of Paliperidone palmitate in the treatment of Schizophrenia in the public health care sector of Hong Kong, Janssen Pharmaceuticals (HK), HKD250,000.00
Prof Kenneth Lee, Dr David Wu, Dr June Choon, (2014-2017). The analysis and publication of Health Economics data for Dapagliflozin in Hong Kong, AstraZeneca Hong Kong Ltd, HKD260,000.00
Prof Kenneth Lee, Dr David Wu, Dr June Choon, (2016-2017). Proposal for study to assess budget impact of Secukinumab in psoriasis, psoriatic arthritis and anklylosing spondylitis in the public sector of Malaysia, Novartis Corp (Malaysia) Sdn Bhd, RM75,000.00
Prof Kenneth Lee, Dr David Wu, Dr June Choon, (2016-2017). Dapagliflozin budget impact analysis model and final budget impact analysis report, AstraZeneca Sdn Bhd, RM46,948.00
Prof Yuen Kah Hay, Dr June Choon, (2010-2015). Neuroprotection by Tocotrienols in Type 1 and Type 2 Diabetes Mellitus (VENUS), PEMANDU, RM3,000,000.00
Alene Yong (PhD: 2020 - Current)
Health economics aspects of end-of-life care among patients with advanced cancer and their caregivers
- Main Supervisor
Subramaniam Thanimalai (PhD: 2019 - Current)
Innovative Patient Access to new Pharmaceuticals -Possible Applications in Malaysia
Membership in Professional Bodies
Member, 2016 - Current
International Society For Pharmacoeconomics and Outcomes Research
Membership in Academic Editorial Committees
Reviewer, 2015- Current
Journal of Pharmaceutical Policy and Practice
Reviewer, Member, 2014 - Current
Value in Health (Regional Issues)
Reviewer, Member, 2013 - Current
International Journal of Marketing Studies